casein kinase 2 (CK2) inhibitors (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecasein kinase 2 (CK2) inhibitors (AstraZeneca)
Drug Alias NameAZ-968AZ-285
ClassificationSmall molecules
Mechanisms of ActionCasein kinase II inhibitorsAnticancer protein kinase inhibitors
TargetsCasein kinase II
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A